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Abstract
Summary We studied the incidence of subsequent fractures in persons of 50+ years from 1990 to 2012 and the relative risk (RR)
of subsequent fractures after an index femur/hip fracture, stratified per 5-year age band. Patients suffering a fracture have a high
incidence of a subsequent fracture; the RR of subsequent fracture after a femur/hip fracture ranged from 2 to 7.
Introduction Recent information on the risk of subsequent fractures after a broad range of index fractures in the UK population is
scarce. We therefore studied the rates of subsequent fractures of the femur/hip, humerus, radius/ulna, vertebrae, rib, or pelvis after
fractures at one of these sites from 1990 to 2012 in 3,156,347 UK men and women aged 50 years or over.
Methods We undertook a retrospective observational study using the UKClinical Practice Research Datalink (CPRD). The incidence
of subsequent fractures at a specific site was calculated by dividing the observed number of fractures by the number of person-years
(py) at risk. The relative risk (RR) of subsequent fractures after a femur/hip fracture, by 5-year age band, was calculated by dividing the
incidence of a specific subsequent fracture type by the incidence of first fractures at the same site in the same age group.
Results The highest subsequent fracture incidence after a femur/hip fracture was for humerus fracture in men (59.5/10.000 py)
and radius/ulna fracture in women (117.2/10.000 py). After an index fracture of the radius/ulna, humerus fracture in men (59.3/
10.000 py) and femur/hip fracture in women (82.4 per 10.000 py) were most frequent. The RR of fractures after a femur/hip
fracture ranged from 2 to 7 and were highest in men and younger age groups.
Conclusion Patients suffering a fracture have a high incidence of a subsequent fracture. Our findings demonstrate the importance
of fracture prevention in patients with a history of a fracture by adequate medical diagnosis and treatment.
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Introduction
The risk of an osteoporotic fracture can be significantly re-
duced by the initiation of appropriate medical treatment in
those at high risk [1]. However, the identification of individ-
uals in the general population at high risk of fracture is chal-
lenging. Although bone mineral density (BMD) is a powerful
predictor of the risk of future fractures, there is little evidence
that BMD-based population screening is cost-effective [2, 3].
Furthermore, because densitometric osteoporosis identifies a
small proportion of the population, and low BMD forms just
one of several risk factors for fracture (for example falls), the
majority of fragility fractures actually occur not in patients
with osteoporosis but in those with osteopenia [4]. There is
strong evidence that a history of a fragility fracture confers an
increased risk of a subsequent fracture [5–9], and indeed, the
UK SCOOP trial demonstrated that screening using 10-year
fracture probability calculated with the FRAX algorithm
(which includes prior fracture as an input variable) leads to a
reduction in the risk of hip fracture and is cost-effective [3].
This increased risk is not limited to prior hip and spine frac-
tures [5] and is to some extent independent of BMD [5].
Despite the development of pharmacological interventions
with proven efficacy [1] and the publication of practice guide-
lines [10, 11], only a minority of patients with an incident
fragility fracture actually receive appropriate treatment [12].
This treatment-gap may, at least partly, be explained by a lack
of awareness of the importance of a prior fracture [13, 14]. It is
critical to determine that the magnitude of subsequent fracture
risk is important so that clinicians and patients might be better
informed about the risk of a sustaining a further fracture and
the potential benefit of treatments which could ameliorate this
risk.
Although several studies [15–19] and meta-analyses [5, 6]
on the risk of subsequent fractures have been published, re-
cent information on the risk of subsequent fractures after a
broad range of index fracture types in the UK population are
scarce [20]. We therefore studied the rates of subsequent frac-
tures at one of six sites (femur/hip, humerus, radius/ulna,
vertebra, rib, or pelvis) after index fractures at one of the same
sites from 1990 to 2012 in UKmen and women aged 50 years
or over, stratified by age.
Methods
Data sources
We conducted a retrospective observational study using data
from the Clinical Practice Research Datalink (CPRD), for-
merly known as the General Practice Research Database
[21, 22]. In the universal health care system in the UK (the
National Health Service, NHS), general practitioners (GPs)
play a pivotal role, providing primary health care for 98%
of the population and referring patients for specialist consul-
tations or hospital admissions. The medical records of the
GPs contain prospective information on demographics, pre-
scriptions, and diagnoses made by GPs and diagnoses from
specialist consultations, outpatient visits, and hospitalizations
[23, 24]. The CPRD covers over 11.3 million individuals
from 674 practices in the UK. Around 4.4 million individuals
are active (alive, currently registered) and meet quality
criteria, accounting for approximately 6.9% of the UK popu-
lation [25]. The cohort as a whole has been shown to be
broadly representative of the UK population in terms of
age, sex, and ethnicity when compared with the UK census
in 2011 [25, 26]. Clinical data for each patient are captured
and stored in CPRD using READ codes for disease or causes
of morbidity or mortality, which are cross-referenced to the
International Classification of Diseases 9th edition (ICD-9)
[27]. The database contains information on both hospital ad-
missions and hospital outpatient attendances, for example
those at an Emergency Department. Information including
date of attendance and diagnosis is passed from the hospital
to the general practitioner, coded, and recorded in the data-
base. Data quality assessments are performed at the practice
level [24]. Independent validation studies have reported that
the clinical data in the CPRD are in general of high quality,
including reliable recording of fracture events [28–30]. This
research was conducted in accordance with the principles of
the Helsinki declaration, and the protocol for this study was
approved by CPRD’s Independent Scientific Advisory
Committee. All data on patients were stored anonymously
in CPRD, and therefore, informed consent was not required
for this study.
Study population
The study population consisted of women and men of 50+
years, who were registered at a participating GP practice be-
tween 1990 and 2012. Fracture types were classified accord-
ing to the ICD-9 classification including the following cate-
gories: clinical vertebra (805,806), rib (807), pelvis (808),
humerus (812), radius/ulna (813), and femur/hip (820,821).
For participants, the first fracture of the femur/hip, humerus,
radius/ulna, vertebra, rib, or pelvis that occurred after the start
of data collection was identified. From the date of this index
fracture, the participants were followed until occurrence of a
subsequent fracture of the femur/hip, humerus, radius/ulna,
vertebrae, rib or pelvis, or censoring (death, withdrawal from
the database, or the end of data collection), whichever came
first. Subsequent fractures at the same site as the index fracture
were excluded from follow-up because it is not possible with-
in the CPRD to identify whether a GP consultation refers to a
new or old fracture.
2470 Osteoporos Int (2018) 29:2469–2475
Statistical analysis
Age- and sex-specific fracture incidence rates were calculated
for all subsequent fracture types. Information on the dates of
start and end of follow-up and the date of subsequent fracture
were available for all patients in CPRD. However, the size of
the database (including records of around 4.4 million individ-
uals) prohibited the practical use of the exact person-time, so
pragmatically, we counted the number of patients who were
enrolled in CPRD at each midyear point (stratified by age and
sex), thus providing the sum of follow-up.
We counted the number of patients who suffered a subse-
quent fracture at a specific site. The average fracture incidence
was then calculated by dividing the sum of patients with a
specific subsequent fracture by the sum of person-time fol-
low-up for the whole period 1990–2012. We calculated the
relative risk (RR) of a subsequent fracture of the humerus,
vertebra, and radius/ulna after an index femur/hip fracture by
5-year age band (the age at the time of diagnosis of the sub-
sequent fracture) using data on the mean age- and sex-specific
fracture incidence rates of a first fracture of the humerus, ver-
tebra, and radius/ulna in the UK in persons 50 years or older
for the period 1990 until 2012 from our previously published
study [21]. The RR was calculated by dividing the incidence
rate of a specific subsequent fracture type by the incidence rate
of a first fracture at the same site. In order to investigate any
possible secular trends in subsequent fracture risk, we calcu-
lated the mean incidences in the first 11 years of follow-up and
the last 11 years separately, using hip/femur and radius/ulna as
the index fractures.We then calculated the incidence rate ratio,
95% confidence interval (CI), and p value using Poisson re-
gression. Analyses were performed using SAS 9.3 (SAS
Institute Inc., Cary, North Carolina, USA) and Stata 13.1
(Statacorp, College Station, Texas, USA). The study was ap-
proved by the Independent Scientific Advisory Committee
(ISAC) for Medicines and Healthcare products Regulatory
Agency database research (ISAC approval 14_032).
Results
In total, we studied data of 3,156,347 persons: 1,457,446 men,
and 1,698,901 women. The average age was 61.5 (SD
12) years; in men, this was 60.5 years (SD 11.2), and in wom-
en 62.3 years (SD 12.7). The absolute number of each index
fracture/ subsequent fracture combination, in both men and
women, can be found in Online Supplementary Table 1A
and 1B.
Incidence of subsequent fractures
A subsequent femur/hip fracture was most frequently ob-
served after an index fracture of the pelvis (Tables 1 and 2).
The highest incidence of subsequent vertebral fracture was
observed in both sexes after an index femur/hip fracture. As
shown in Online Supplementary Fig. 1, the incidence of sub-
sequent fracture after an index femur/hip fracture increased
with age only for fractures of the pelvis in women of 70 years
or older. After an index vertebral fracture, an increase in sub-
sequent fracture incidence was seen in hip fractures in women
above 60 years and in pelvic fractures in women above
65 years and men above 75 years (Online Supplementary
Figs. 2 and 3).
Age-specific incidence of subsequent fractures
after an index fracture of the hip
The incidence of a subsequent vertebral fracture after an index
fracture of the femur/hip varied in men from 14.5 fractures per
10,000 py for the age class 50–54 years to 56.1 fractures per
10,000 py for those aged 60–64 years (Table 3). In women, the
corresponding incidence ranged from16.0 for age 55–59 years
to 56.1 for those aged 60–64 years. For subsequent fracture of
the humerus after femur/hip fracture, the incidence varied
from 44.5 for the age class 60–64 years to 75.8 for those aged
55–59 years in men and from 61.8 for the age class 60–
69 years to 106.6 for those aged 50–54 years in women.
Relative risk for subsequent fractures
The highest RRs after an index femur/hip fracture were in
general found in the younger age classes, while the RRs in
the oldest age classes were in general the lowest (Table 4). The
RR of a subsequent vertebral fracture and fracture of the hu-
merus was in general higher inmen than in women. The RR of
a subsequent vertebral fracture after an index fracture of the
femur/hip varied in men from 1.8 for the age class 90+ years
to 17.5 for those aged 60–64 years (Table 4). In women, this
RR ranged from 1.6 for the age class 90+ to 11.5 for those
aged 60–64 years. The RR of a subsequent fracture of the
humerus after an index fracture of the femur/hip in men varied
from 2.7 for the age class 85–89 years to 12.9 for those aged
55–59 years (Table 4). In women, this RR ranged from 2.2 for
the age class 90+ years to 14.2 for those aged 50–54 years.
There was no evidence of any statistically significant differ-
ence in incidence rates of fractures after an index hip/femur
fracture or radius/ulna fracture comparing the second (2001–
2012) with the first (1990–2012) half of the calendar period
for men. However, for women, there was evidence of a secular
increase in the risk of subsequent vertebral fracture after radi-
us/ulna, a decrease in rib after hip/femur or radius/ulna index
fractures, and a decrease in radius/ulna fractures after hip/
femur fracture comparing the latter with an earlier calendar
period (Online Supplementary Table 2A and 2B).
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Discussion
In this retrospective, observational study, using data from the
CPRD database, we have described the incidence of subse-
quent fractures after a first fracture of the femur/hip, humerus,
radius/ulna, vertebra, rib, or pelvis in the UK in persons
50 years or older for the period 1990 to 2012, together with
the RR of fractures of the humerus, radius/ulna, or vertebra
after an index femur/hip fracture. We found that patients suf-
fering a fracture in general have a high incidence of a subse-
quent fracture. The RR of a subsequent fracture after a femur/
hip fracture (compared with a first fracture at the same site)
was highest in the younger age groups and inmen, and inmost
subgroups ranged from 3 to 7 for subsequent vertebral fracture
and fracture of the humerus, and from 2 to 5 for subsequent
fractures of the radius/ulna.
In general, our results are consistent with, and extend, find-
ings ofmeta-analyses and cohort studies published previously.
In a study from the UK published in 2002 [15], using the same
CPRD database, there was a 2- to 3-fold increase in the risk of
subsequent fractures at different skeletal sites after an index
femur/hip fracture. This lower increase in fracture risk can be
explained by the fact that in this study, persons 20 years or
older were included, while we studied patients of 50 years or
older. In the study from 2002, the standardized incidence ratio
(SIR) of a subsequent vertebral fracture or fracture of radius/
ulna after a femur/hip fracture was also determined in both
men and women in the age groups 65–74, 75–84, and 85+
years. In women, the SIR of fractures of the radius was lower
than our RR in all three age groups, whereas the SIR of ver-
tebral fractures was lower than the RR we found only in the
age group 65–74 years, while in the other two age groups, the
values were similar. In men in the age group 65–74, the SIR
for both vertebral fractures and fractures of radius/ulna was
higher than the RR we found; in the other two age groups, the
results overall were similar to our results. A secular trend in
subsequent fractures was recently described in a study using
the same CPRD database to determine the absolute risk of
fragility fractures after an index femur/hip fracture [20]. In this
study, the authors reported an increase in the risk of sustaining
a major or any (non-hip) fracture after a femur/hip fracture,
especially in the longer term with 32.5% of the patients sus-
taining a fracture after 5 years.
In line with the findings of van Staa et al. [15], our study
suggests that the RR for subsequent fractures was generally
higher inmen then inwomen, which has also been observed in
other studies [31]. We found that the RR of subsequent frac-
tures was higher among younger persons compared with older
individuals, and again, this is in keeping with the results from
the UK study from 2002 [15]. These findings in relation to
men and younger ages probably reflect that sustaining a frac-
ture in these situations is an uncommon event which therefore
particularly marks an individual out as being at higher fracture
risk than their peers (i.e., relative to the background popula-
tion risk). This is consistent with the lower absolute incidences
of second fracture in these groups compared with those in
Table 1 Average incidence per
10,000 person-years of subse-
quent fracture from 1990 to 2012
in men aged 50+ years
Subsequent fracture
Index fracture Hip/femur Vertebra Humerus Radius/ulna Pelvis Rib
Hip/femur 41.7 59.5 37.8 33.5 24.4
Vertebra 70.7 44.0 25.9 18.8 47.3
Humerus 68.7 25.6 71.3 9.1 20.7
Radius/ulna 38.5 3.5 59.3 7.2 17.9
Pelvis 139.2 49.4 71.7 37.1 38.2
Rib 32.7 30.3 24.4 27.7 7.0 a
a The number of fractures was too few to calculate meaningful incidence rates
Table 2 Average incidence per
10,000 person-years of subse-
quent fracture from 1990 to 2012
in women aged 50+ years
Subsequent fracture
Index fracture Hip/femur Vertebra Humerus Radius/ulna Pelvis Rib
Hip/femur 44.5 88.2 117.2 62.2 19.1
Vertebra 154.8 71.8 93.4 58.6 37.9
Humerus 116.5 36.3 154.9 29.5 16.0
Radius/ulna 82.4 27.4 80.1 19.4 14.9
Pelvis 264.3 74.4 107.3 144.9 32.1
Rib 87.2 55.2 63.0 96.5 26.7 a
a The number of fractures was too few to calculate meaningful incidence rates
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women and at older ages; in these latter situations, the back-
ground population risk is higher and the occurrence of a frac-
ture is likely to have less of a relative impact on future fracture
risk. The increase with age in the incidence of pelvis, vertebra,
and hip fractures following an index fracture is consistent with
the known epidemiology of these fractures, and that changes
in neuromuscular ability with age, for example, the tendency
to fall backward or sideways rather than forwards, lead to
particular increases in these fracture types compared with
those of the upper limb. The younger average age of radius/
ulna fractures as the index fracture will permit this age-related
pattern to be more visible compared with hip as the index
fracture (which tend to occur at older ages).
Two previous meta-analyses have given rather lower RR
for subsequent fractures: In the first [6], the RR of a subse-
quent fracture (any, hip, vertebral, or wrist) was 2.4 for those
with a prior hip fracture and approximately 2 for the other
types of prior fractures. In a meta-analysis from 2004 [5],
the RR of a subsequent fracture in men and women combined
ranged from 1.8 to 2. In a recent study from Denmark [16]
examining subsequent fracture rates by observing a cohort of
patients aged 50 years or older from 2001 to 2011, patients
suffering an index fracture (especially a hip fracture) had a
high incidence of subsequent fractures. Depending on the type
of initial fracture, the risk of a subsequent fracture within the
following 10 years in men ranged from 5 to 15% for forearm
fractures, 8–24% for humerus fractures, and 9–34% for hip
fractures. For women, the equivalent rates were 11–25, 9–27,
and 13–40%, respectively. In a recent international,
questionnaire-based study in women of 55 years or older
and with a follow-up of 2 years [17], the authors found that
the risk of a subsequent fracture increased with the number of
prior fractures. The RR of any fracture was 1.8 in women with
one prior fracture increasing to 3 in those with two prior frac-
tures and to 4.8 in women with more than two prior fractures.
The varied RR across studies can be explained, at least to
some extent, by the difference in studied populations, differ-
ences in fracture outcomes (for example, we studied hip/femur
rather than hip alone), and other methodologies used. Because
of the long period we studied, coinciding with the introduction
of several effective antiosteoporosis medications and im-
provements in primary and secondary prevention, we consid-
ered the possibility that subsequent fracture risk has changed
during the studied 22-year period. The reduction in subse-
quent rib fractures in women in the later compared with earlier
period corresponds well with the reduction in rib fracture in-
cidence from 1990 to 2012 we observed in an earlier study
[21]. This may reflect a reduction reporting of rib fractures as a
result of changes to clinical assessment rather than a true sec-
ular change in incidence [21], but with this as with the other
potential secular differences we observed, other changes such
as alterations to the age and ethnicity distribution of the cohort
over time will also have made contributions.
In the meta-analysis from 2004 [5], correction for BMD
only lowered the risk of subsequent fractures by approximate-
ly 10%, emphasizing the importance of prior fractures with
regard to future fracture risk, and showing that this risk is to
some extent independent of BMD. In a study from Canada
from 2009 [18], the RR for low-trauma fracture in persons 50–
90 years of age with a prior fracture was 14.6 in men with
osteoporosis and 9.2 in women with osteoporosis. In men and
women with osteopenia, this was 4.1 and 5.5, respectively,
and in the group of individuals with a normal BMD, men
had a RR of 6.4, while the RR in women was not statistically
significantly raised. The authors found that subsequent clini-
cally symptomatic low-trauma fractures constitute one quarter
Table 3 Incidence of subsequent fractures per 10,000 py after a hip/




Age (years) M F M F M F
50–54 14.5 24.1 50.9 106.6 43.5 48.5
55–59 21.4 16.0 75.8 68.6 76.3 97.5
60–64 56.1 32.7 44.5 61.8 36.3 90.8
65–69 29.2 37.8 52.2 90.5 39.1 89.3
70–74 25.6 49.8 59.2 97.4 33.4 142.6
75–79 39.9 50.4 59.2 85.4 26.7 129.3
80–84 51.6 53.8 55.1 87.1 28.3 129.6
85–89 55.0 43.0 57.2 87.6 33.4 115.9
90+ 34.6 37.0 69.3 94.0 58.9 101.1
M males, F females
Table 4 Relative risk of subsequent fractures after hip/femur fracture in
persons aged 50+, by 5-year age class, in the UK from 1990 to 2012
Subsequent fracture site
Vertebra Humerus Radius/ulna
Age (years) M F M F M F
50–54 6.9 11.5 8.5 14.2 8.3 3.7
55–59 9.3 6.1 12.9 7.1 9.4 5.5
60–64 17.5 8.8 7.2 5.6 4.5 4.3
65–69 7.9 7.0 7.6 6.9 5.0 3.6
70–74 5.0 6.0 7.6 5.8 4.0 5.0
75–79 5.1 3.9 5.9 3.9 2.6 3.6
80–84 4.6 2.9 3.8 3.0 2.4 3.0
85–89 3.3 1.9 2.7 2.3 2.0 2.3
90+ 1.8 1.6 2.8 2.2 3.1 1.8
M males, F females
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of the overall fracture burden inmen and just under one half of
the fracture burden in women [18]. Conversely, in a recent
study from Australia [19], the RR of subsequent fracture
was > 2.0-fold for all levels of BMD, demonstrating the high
burden of subsequent fracture across all levels of BMD score.
Our study has some limitations that should be considered in
the interpretation of our results. Firstly, although in general,
fractures recorded in CPRD have been shown to be reliably
coded [28], it is nevertheless possible that some fractures may
have been misclassified as soft tissue injuries or incorrectly
coded. In common with many other primary care databases,
it is possible that fractures treated purely on an outpatient basis
may have been less reliably captured than those necessitating
hospital admission, most likely leading to an underestimate of
incidence rates overall. Secondly, it is well-established that
vertebral fractures are underdiagnosed [32], and this means that
the incidences of subsequent vertebral fractures we found are
also probably underestimated. Thirdly, owing to the difficulty
in distinguishing two separate fractures of the same site that
occur close in time, from a second reporting of the first fracture,
we did not include subsequent fractures at the same individual
site, which is likely to have resulted in an underestimate of
fracture incidence, especially because subsequent fractures at
the same anatomical (ipsilateral or contralateral) site have a
relative high incidence [15, 33]. This limitation will probably
particularly affect the detection of multiple vertebral fractures.
Furthermore, we were not able to explore the timecourse of the
risk relationship, as has been undertaken elsewhere [34].
Fourthly, because of the extremely large number of individuals
in the dataset, it was not possible to readily calculate incidences
on the basis of exact dates of fracture and time at risk. Although
this will have led to someminor loss of resolution in the results,
this factor is unlikely to have systematically changed our find-
ings overall. Fifthly, due to inherent limitations of our database,
we were not able to provide information with regard to the
duration of the time to a subsequent fracture. Sixthly, CPRD
covers 7% of the UK population [25] and therefore may not
fully represent fracture rates in all areas of the UK. However,
the dataset has been shown to be generally representative of the
UK population [25]. Additionally, we were not able to inves-
tigate whether fracture risks might have changed in the years
subsequent to 2012. Finally, we did not take competing mor-
tality risks into account, which can potentially cause an under-
estimation of the probability (accounting for death risk) of
subsequent fractures, especially after hip and vertebral frac-
tures [35, 36], and potentially differential by sex, since death
rates differ between men and women. Importantly, the figures
we report document the fractures that actually happened, rather
than the theoretical incidence that might occur after accounting
for death rates and thus are likely to be the appropriate metric to
inform approaches to risk assessment.
In conclusion, we have demonstrated in the UK CPRD that
an index fracture is associated with a markedly raised risk of
subsequent fractures, with, for example, a relative risk of sub-
sequent fractures after an index hip fracture between 2 and 7
compared with the risk of a first fracture at these sites. Our
findings strongly support the need for prompt appropriate as-
sessment and treatment to reduce risk of future fractures, fol-
lowing an index event in persons aged 50+ years and that
resource is urgently needed to close the current care gap ex-
perienced by many patients with osteoporosis worldwide.
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